Scilex Holding (SCLXW) Equity Average (2020 - 2026)

Scilex Holding (SCLXW) recorded quarterly Equity Average of -$230.9 million in Q1 2026, down 20.05% quarter-over-quarter from -$192.4 million in Q4 2025, and down 14.28% on a YoY basis from -$269.4 million in Q1 2025.

Scilex Holding (SCLXW) Equity Average (2020 - 2026) Analysis & Trends

Scilex Holding's Equity Average history runs 7 years deep, the most recent figure standing at -$230.9 million for Q1 2026.

  • In Q1 2026, Equity Average fell 14.28% year-over-year to -$230.9 million; the TTM figure through Mar 2026 stood at -$230.9 million (down 14.28% YoY), while the FY2025 annual figure was -$200.2 million, down 9.53% from the prior year.
  • Equity Average was -$230.9 million for Q1 2026 at Scilex Holding, down from -$192.4 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $23.7 million in Q1 2023 to a low of -$241.8 million in Q2 2022.
  • Historically, Equity Average has averaged -$169.6 million across 5 years, with a median of -$202.1 million in 2025.
  • The sharpest annual moves came in 2022 and 2023: Equity Average tumbled 2824.72% in 2022, then surged 110.39% in 2023.
  • A 5-year view of Equity Average shows it stood at -$96.6 million in 2022, then sank by 73.75% to -$167.8 million in 2023, then declined by 20.37% to -$202.0 million in 2024, then rose by 4.76% to -$192.4 million in 2025, then fell by 20.05% to -$230.9 million in 2026.
  • The last three Equity Average figures came in at -$230.9 million (Q1 2026), -$192.4 million (Q4 2025), and -$213.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 28.87 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 81.37 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -4.96 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 49.27 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 8.92 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 23.11 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 88.29 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 19.27 Bn
10 Scilex Holding - - 4.15 Mn -230.93 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -230.93 Mn
Dec 31, 2025 -192.36 Mn
Sep 30, 2025 -212.96 Mn
Jun 30, 2025 -230.24 Mn
Mar 31, 2025 -202.06 Mn
Dec 31, 2024 -201.98 Mn
Sep 30, 2024 -213.00 Mn
Jun 30, 2024 -202.24 Mn
Mar 31, 2024 -181.36 Mn
Dec 31, 2023 -167.80 Mn
Sep 30, 2023 -76.13 Mn
Jun 30, 2023 10.75 Mn
Mar 31, 2023 23.66 Mn
Dec 31, 2022 -96.58 Mn
Sep 30, 2022 -240.75 Mn
Jun 30, 2022 -241.83 Mn
Mar 31, 2022 -227.72 Mn
Dec 31, 2021 -116.85 Mn
Sep 30, 2021 -9.11 Mn
Jun 30, 2021 -8.27 Mn